The effect of date seed (phoenix dactylifera) extract on paraoxonase and arylesterase activities in hypercholesterolemic rats

Jundishapur Journal of Natural Pharmaceutical Products

Volumn 9, Issue 1, 2014, Pages 30-34

  Takaeidi, Mohammad Reza ^a   Jahangiri, Alireza ^a   Khodayar, Mohammad Javad ^a   Siahpoosh, Amir ^a   Yaghooti, Hamid ^a   Rezaei, Saeid ^a   Salecheh, Maryam ^a   Mansourzadeh, Zahra ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidants; Aryldialkylphosphatase; Arylesterase; Rats

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; ATORVASTATIN; HYPOCHOLESTEROLEMIC AGENT; PHOENIX DACTYLIFERA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DATE (FRUIT); DIET; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; ENZYME ACTIVITY; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; PLANT SEED; RAT; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 84894279328     PISSN: 17357780     EISSN: 22287876     Source Type: Journal    
DOI: 10.17795/jjnpp-10368     Document Type: Article

References (24)

1. Costa LG, Giordano G, Furlong CE. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. Biochem Pharmacol. 2011;81(3):337-44.
2. Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers. 2003;8(1):1-12.
3. Aviram M. Introduction to paraoxonases. J Lipids. 2012;2012:1-3.
4. Androutsopoulos VP, Kanavouras K, Tsatsakis AM. Role of paraoxonase 1 (PON1) in organophosphate metabolism: implications in neurodegenerative diseases. Toxicol Appl Pharmacol. 2011;256(3):418-24.
5. Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci. 2009;46(2):83-106.
6. Camps J, Marsillach J, Joven J. Pharmacological and lifestyle factors modulating serum paraoxonase-1 activity. Mini Rev Med Chem. 2009;9(8):911-20.
7. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol. 2005;69(4):541-50.
8. Tomas M, Senti M, Garcia-Faria F, Vila J, Torrents A, Covas M, et al. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2000;20(9):2113-9.
9. van Wijk J, Coll B, Cabezas MC, Koning E, Camps J, Mackness B, et al. Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients. Clin Exp Pharmacol Physiol. 2006;33(12):1134-7.
10. Wojcicka G, Jamroz-Wisniewska A, Marciniak A, Lowicka E, Beltowski J. The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity. Life Sci. 2010;87(3-4):126-32.
11. Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B, et al. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atheroscler. 1998;139(2):341-9.
12. Kiyici A, Okudan N, Gokbel H, Belviranli M. The effect of grape seed extracts on serum paraoxonase activities in streptozotocininduced diabetic rats. J Med Food. 2010;13(3):725-8.
13. Koren-Gluzer M, Aviram M, Meilin E, Hayek T. The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates beta-cell insulin release. Atherosclerosis. 2011;219(2):510-8.
14. Baliga MS, Baliga BRV, Kandathil SM, Bhat HP, Vayalil PK. A review of the chemistry and pharmacology of the date fruits (Phoenix dactylifera L.). Food Res Int. 2011;44(7):1812-22.
15. Al-Farsi MA, Lee CY. Nutritional and functional properties of dates: a review. Crit Rev Food Sci Nutr. 2008;48(10):877-87.
16. Vayalil PK. Date fruits (Phoenix dactylifera Linn): an emerging medicinal food. Crit Rev Food Sci Nutr. 2012;52(3):249-71.
17. Soong YY, Barlow PJ. Antioxidant activity and phenolic content of selected fruit seeds. Food Chem. 2004;88(3):411-7.
18. Al-Farsi MA, Lee CY. Optimization of phenolics and dietary fibre extraction from date seeds. Food Chem. 2008;108(3):977-85.
19. Besbes S, Blecker C, Deroanne C, Drira NE, Attia H. Date seeds: chemical composition and characteristic profiles of the lipid fraction. Food Chem. 2004;84(4):577-84.
20. Nguyen SD, Sok DE. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Free Radic Res. 2003;37(12):1319-30.
21. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med. 2005;38(2):153-63.
22. Mirdamadi HZ, Sztanek F, Derdak Z, Seres I, Harangi M, Paragh G. The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters. Br J Clin Pharmacol. 2008;66(3):366-74.
23. Kassai A, Illyes L, Mirdamadi HZ, Seres I, Kalmar T, Audikovszky M, et al. The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase. Clin Biochem. 2007;40(1-2):1-5.
24. Dullaart RP, de Vries R, Voorbij HA, Sluiter WJ, van Tol A. Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus. Eur J Clin Invest. 2009;39(3):200-3.